AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05633511 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Split Mouth Design
Description: PRF on one side of mouth and CTG on the other side of participant's mouth.
Study NCT06365528 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Non-tunnelling
Description: The Non-tunnelling group will have PICC placement with the traditional method under ultrasonography. Procedures will be implemented under hand hygiene, maximal sterile barrier, and chlorhexidine. The targeted arm will be sterilized with a mixture of chlorhexidine and isopropyl alcohol, and a sterile drape will be placed to cover the entire procedure feld from head to toe. After vein puncture with the access needle, a Nitinol guidewire will be placed. After, a peel-away sheath will be placed over the wire. The catheter will be trimmed to the distance between the venepuncture site and cavoatrial junction.
Study NCT00594373 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenofovir gel
Description: 1 gm/100 ml of 1% tenofovir gel vaginally daily
Study NCT00594373 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Tenofovir gel placebo
Description: 1 gm/100 ml of placebo gel vaginally daily
Study NCT05509517 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Photoplethysmography based smartphone application for heart rhythm analysis (FibriCheck™)
Description: Heart Rhythm assessment using the FibriCheck™ application with the patient's proprietary smartphone, three times daily, from discharge until follow-up consultation (day 21-91 after discharge).
Study NCT06194617 — intervention group
Intervention type: DRUG
Intervention: Direct oral anticoagulant
Description: Patients take DOACs according to their condition, with the dosage determined by the clinical physician.
Study NCT04931979 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab Injection [Keytruda]
Description: Up to 17 cycles of pembrolizumab until disease progression, toxicity, death, or withdrawal of IC (whichever occurs first)
Study NCT04931979 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Salvage Radiation Therapy (SRT)
Description: SRT according to standard of care (SRT with at least 66 Gy)
Study NCT06147427 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ACL reconstruction with hamstrings combined with ALL plasty
Description: ACL reconstruction with hamstrings combined anterolateral plasty using the ALL reconstruction technique (Gracilis throught the femur tunnel of the ACL graft and fixed to the tibia by an anchor on its point of isometry on the tibia).
Study NCT06147427 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ACL reconstruction with hamstrings combined with modified Lemaire's LET
Description: ACL reconstruction with hamstrings combined with modified Lemaire's lateral extra-articular tenodesis technique (Fascia lata strip pedicled to the Gerdy and fixed to the femur throught the tunnel of the ACL graft).
Study NCT05502445 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: educational intervention
Description: In this group, the steps below are added:on the first day, the delivery of the leaflet on the importance of nutrition in the hospital environment will be added in addition to verbal guidance. On the second day, an educational institutional video with duration of two minutes, will be shown with the title Food Intake and Oral Supplement in Nutritional Rehabilitation via tablet or mobile phone.~When the 24-hour recall will be collected, an assessment of food intake will be performed, mainly of foods that are sources of protein and, when they were less than 75%, strategies must be designed to increase the acceptance or indication of oral nutritional supplements.
Study NCT04952870 — intervention group
Intervention type: OTHER
Intervention: Inhaled NO
Description: Newborn or young infants (\< 3 months) receiving inhaled NO as part of their treatment for severe respiratory failure
Study NCT06321770 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bioactive collagen peptides
Description: 2,5 g collagen peptides
Study NCT06321770 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo sachet daily
Study NCT06578065 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Echelon Circular™ Powered Stapler
Description: Echelon Circular™ Powered Stapler will be used in colorectal anastomosis.
Study NCT06578065 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 2-row circular staplers manual
Description: 2-row circular staplers manual will be used in colorectal anastomosis.
Study NCT05471089 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Diathermy by emission of Radiofrequency
Description: Applied only to experimental group
Study NCT05471089 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Therapeutic exercise
Description: Applied to both arms/groups
Study NCT04952870 — intervention group
Intervention type: OTHER
Intervention: routine care
Description: Patients treated for respiratory failure
Study NCT05300490 — intervention group
Intervention type: DRUG
Intervention: Prednisolone
Description: In this routine care study, all patients will receive a joint injection of prednisolone at a dose left to the discretion of the physician. The urinary excretion kinetics of this product and its metabolites will then be followed at different times. An association with metabolic genetic profile will be done.
Study NCT04924829 — intervention group
Intervention type: DRUG
Intervention: Tocilizumab
Description: Tocilizumab received as a single intravenous infusion over the period of 60 minutes. Dose of 8 mg/kg, maximum dose of 800 mg.
Study NCT05584696 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Green light exposure
Description: The experimental group wears green color glasses ten minutes before surgery until it ends.
Study NCT05584696 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Normal light exposure
Description: The control group wears green color glasses ten minutes before surgery until it ends.
Study NCT05705284 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Structured multidisciplinary medication review
Description: Multidisciplinary process for medication review/deprescribing: The intervention will be a structured process for performing a shared-decision, person-centred medication review among those living with frailty involving GPs, PCN-pharmacist and ANPs.
Study NCT05219747 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mucoadhesive film containing Acmella oleracea extract
Description: Participants will apply a mucoadhesive film containing Acmella oleracea extract on labial mucosa of lower lip by themselves at least for 2 hours
Study NCT05219747 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Mucoadhesive film without Acmella oleracea extract
Description: Participants will apply a mucoadhesive film on labial mucosa of lower lip by themselves at least for 2 hours
Study NCT06580990 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: specific neck exercises with the Spinetrack
Description: This group will receive an telerehabilitation exercise programme for the deep neck musculature using the spinetrack
Study NCT06580990 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: specific neck exercises
Description: This group will receive a telerehabilitation programme with exercise for the deep neck musculature
Study NCT05095077 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tadalafil 40 MG
Description: Single dose on study day 1/2
Study NCT05093660 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood specimen collection
Description: Blood specimen collection for analysis of CRP (C-reactive protein), WBC (White blood cells) and LRG1 (Circulating Human Leucine-rich α-2-glycoprotein) levels
Study NCT05093660 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Saliva specimen collection
Description: Saliva specimen collection for analysis of LRG1 (Circulating Human Leucine-rich α-2-glycoprotein) levels
Study NCT05471089 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapeutic exercise
Description: Applied to both arms/groups
Study NCT05168020 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Safety Behavior Fading for Social Anxiety
Description: Participants are asked to reduce or eliminate safety behaviors via text message reminders and checklists to monitor progress
Study NCT05168020 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Unhealthy Behavior Fading
Description: Participants are asked to reduce or eliminate unhealthy behaviors via text message reminders and checklists to monitor progress
Study NCT05431504 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dalpiciclib in combination with endocrine therapy by Physicians choice
Description: Dalpiciclib 150 mg orally once daily for 3 weeks, followed by 1 week off in each 4-week cycle.~Endocrine therapy including but not limited to fulvestran, tanastrozole, letrozole or exemestane In regular doses
Study NCT06584266 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Transoesophageal echocardiography
Description: Imaging data obtained with transoesophageals echocardiography will be retained as well as data from transthoracic echocardiography and from other imaging modalities, if available
Study NCT05095077 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Identical to active IMP
Study NCT06584266 — intervention group
Intervention type: PROCEDURE
Intervention: Catheter ablation
Description: Cathether ablation of atrial fibrillation substrate using one of available methods.
Study NCT05974267 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: M5717 60 mg
Description: Participants will receive single oral dose (Capsules) of 60 mg M5717 on Day 1 under fasting condition
Study NCT05974267 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyronaridine
Description: Participants will receive Pyronaridine tablets orally single dose of 720 (Participants >= 65 kg) and 540 mg (Participants >= 45 to \< 65 kg) on Study Day 1 under fasting condition
Study NCT06584058 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HPP737
Description: \[14C\]HPP737 oral preparation, 20mg（150μCi）, once
Study NCT06583278 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: transcranial magnetic stimulation
Description: The stimulations were performed by MagStim Rapid2.
Study NCT06583278 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial magnetic stimulation
Description: The stimulations were performed by MagStim Rapid2.
Study NCT06584461 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine (drug)
Description: IV lidocaine, administered once during the induction of anesthesia.
Study NCT06584461 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline (NaCl 0,9 %) (placebo)
Description: IV placebo (normal saline), administered once during the induction of anesthesia.
Study NCT06583889 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Heparin
Description: The patients randomized to standard medical care will receive (or continue) either any type of body-weight adjusted low molecular weight heparin in therapeutic dose, or intravenous adjusted dose unfractionated heparin (aPTT value kept within 1 time the normal value), according to the existing international guidelines.
Study NCT06583889 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endovascular treatment
Description: Standard endovascular techniques to mechanically remove clot material, such as mechanical thrombectomy and/or balloon angioplasty and/or local application of alteplase or urokinase within the thrombosed sinuses.
Study NCT04430933 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NC318
Description: NC318 is an experimental antibody drug that will be administered by IV infusion on the first day of each 21 day cycle
Study NCT05974267 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atovaquone-Proguanil
Description: Participants will Receive Atovaquone-Proguanil tablets 1000/400 mg once daily in a 3-day treatment regimen.
Study NCT05974267 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: M5717 200 mg
Description: Participants will receive single oral dose (Capsules) of 200 mg M5717 on Day 1 under fasting condition
Study NCT05974267 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: M5717 660mg
Description: Participants will receive single oral dose (Capsules) of 660 mg M5717 on Day 1 under fasting condition
Study NCT05818475 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Angiography-guided PCI
Description: Non-culprit lesion treatment will be based on visual estimation by angiography. The evaluation of PCI result will be also based only on angiography.
Study NCT05818475 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Angiography-derived FFR PCI indication and planning
Description: Non-culprit lesion treatment will be based on angiography-derived FFR result. In case of positive assessment, PCI will be planned according to the virtual PCI plan based on the physiology pullback curve.
Study NCT06096766 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: blood test
Description: Detection of serum levels of copper ions, iron ions, ceruloplasmin (CP), CuZn SOD, malondialdehyde (MDA), etc. Blood samples will be retained from the rest samples for sex hormones samples for testing sex hormones, which don't increase times of blood collection.
Study NCT04731233 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Plasma Rich in Growth Factor (PRGF) Supplementation
Description: After rinsing the joint, the TMJ will be injected with blood plasma rich in growth factors (PRGF). PRGF supplementation which is an autologous platelet-enriched plasma obtained from patient's own blood, which after activation with calcium chloride allows the release of a pool of biologically active proteins that influence and promote a range of biological processes.
Study NCT04731233 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triamcinolone Acetonide
Description: After rinsing the joint, the TMJ will be injected with 40 mg of triamcinolone acetonide with 5 mg bupivacaine.
Study NCT06482957 — intervention group
Intervention type: OTHER
Intervention: Surveys
Description: Complete surveys
Study NCT06482957 — intervention group
Intervention type: OTHER
Intervention: Blood Collection
Description: Undergo blood collection
Study NCT06482957 — intervention group
Intervention type: OTHER
Intervention: Saliva Collection
Description: Undergo salvia collection
Study NCT06482957 — intervention group
Intervention type: OTHER
Intervention: Urine Collection
Description: Undergo urine collection
Study NCT06482957 — intervention group
Intervention type: OTHER
Intervention: Stool Collection
Description: Undergo stool collection
Study NCT06482957 — intervention group
Intervention type: OTHER
Intervention: Tissue collection
Description: Undergo tissue collection
Study NCT06482957 — intervention group
Intervention type: OTHER
Intervention: Physical Activity Monitoring
Description: FitBit will be worn to track physical activity
Study NCT05342727 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: transcranial direct current stimulation (tDCS)
Description: In tDCS, direct electrical currents at the intensity of interest (2 mA for example) are generated by an electrical stimulator and are noninvasively delivered to the scalp through a pair of saline-soaked sponge electrodes (7×5 cm).
Study NCT05342727 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: transcranial alternating current stimulation (tACS)
Description: In tACS, alternating electrical currents at the frequency of interest (8 Hz for example) are generated by an electrical stimulator and are noninvasively delivered to the scalp through a pair of saline-soaked sponge electrodes (7×5 cm).
Study NCT05879016 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional Correction Technique
Description: A single I strip will be used for this technique. Taping will be done by applying moderate (25-35%) degree of stretching to the middle 1/3 of the tape, with the stretched area centered on the trigger point. The ends of the tape will be adhered without stretching.
Study NCT05879016 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fascia Correction Technique
Description: Y tape will be applied to prevent fascia adhesions. In the Y tape application, first the tail strips of the Y will be adhered with maximum tension so that the muscle fiber is transverse. Then it will be glued so that its base is in front of the pain point. No tension will be applied to the ends of the tape. The application will be applied when the patient is in a resting position and his joints are in a tense position.
Study NCT05879016 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Star Taping Technique
Description: 4 I tapes of the same length between 15 cm and 20 cm will be glued on top of each other. After the first I tape is adhered, the 2nd I tape will be adhered at 90 degrees, then the 3rd and 4th I tapes will be adhered at 45 degrees to obtain a star appearance. There will be no tension at the ends of the tapes
Study NCT05879016 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Comparator
Description: I shape tape will be adhered for sham purpose without applying any tension.
Study NCT04879576 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treatment
Description: Telerehabilitation including pulmonary rehabilitation and posture exercises at 8 weeks in total with 2 sessions per week
Study NCT05413655 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EX039
Description: The dosage form of EX039 is the capsule for oral use
Study NCT05413655 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The dosage form of Placebo is the capsule for oral use
Study NCT05870358 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Melatonin 3 MG
Description: In this clinical trial, all patients that have both diabetes mellitus and periodontitis were performed full mouth scaling and root planning in order to start their periodontal treatments. Different from the control group, in fmSRP-mel group's patients systemic melatonin tablets (6 mg daily, for 30 days) were given immediately after the fmSRP procedure in order to support the scaling and root planning.
Study NCT06452680 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Preserving IPL during surgery
Description: IPL was preserved during surgery
Study NCT05249504 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VIVIFRAIL
Description: VIVIFRAIL is a set of physical activity programs (designed according to several elderly functional level profiles) aimed to prevent motor disability and improve quality of life. It works endurance, flexibility, balance and strength.~https://web.archive.org/web/20210907041944/https://vivifrail.com/
Study NCT05249504 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutrition
Description: Sessions to learn about personal nutrition habits, offer nutritional advice, and acquire skills to incorporate simple healthy nutrition guidelines into everyday life. A visit to a supermarket to make it easier to read and understand the basic information on nutrition labels.
Study NCT05249504 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychology
Description: Relaxation techniques to manage mood, a photo-elicitation dynamic to address loneliness, and a dynamic to collectively develop a map of health assets in the neighborhood or territory to obtain information on community resources. Finally, a group visit is planned to a community facility previously agreed upon by the participants.
Study NCT05249504 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Personal autonomy
Description: Review practical cases on personal autonomy, the proper use of medications, and discover basic cognitive stimulation strategies.
Study NCT05249504 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Community resources
Description: Learn about community resources
Study NCT05249504 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard recommendations
Description: Usual advice provided at primary care office accompanied to booklets about healthy lifestyles
Study NCT06115590 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nutritional supplement
Description: Nutritional intervention hypothesized to have an acute anxiolytic effect
Study NCT05573126 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EP0062
Description: EP0062 is an orally administered investigational selective androgen receptor modulator (SARM)
Study NCT04430933 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed/Carboplatin
Description: Pemetrexed/Carboplatin will be administered per the approved respective product label following the infusion of NC318 on the first day of each 21 day cycle
Study NCT06245668 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SaCoVLM™ video laryngeal mask
Description: The SaCoVLM™ video laryngeal mask will be placed directly into the hypopharyngeal space until resistance is felt, following the recommended instructions for use.
Study NCT05891496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: Semagllutide will be administered once weekly subcutaneously.
Study NCT05891496 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Semaglutide
Description: Semagllutide will be administered once weekly subcutaneously.
Study NCT05891496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo matched to semaglutide will be administered once weekly subcutaneously.
Study NCT04430933 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab paclitaxel/Carboplatin
Description: Nab-paclitaxel/Carboplatin will be administered per the approved respective product label following the infusion of NC318 on the first day of each 21 day cycle